- Record: found
- Abstract: found
- Article: found
Patient-reported outcomes from FLAURA: Osimertinib versus erlotinib or gefitinib in patients with EGFR-mutated advanced non-small-cell lung cancer
Natasha B. Leighl ,
Nina Karaseva ,
Kazuhiko Nakagawa ,
Byoung-Chul Cho ,
Jhanelle E. Gray ,
Tina Hovey ,
Andrew Walding ,
Anna Rydén ,
Silvia Novello
January 2020
January 2020
Read this article at
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.